Afridi’s PCR test negative
KARACHI: Quetta Gladiators’ experienced all-rounder Shahid Afridi’s PCR test returned negative on Sunday.
A Gladiators source told ‘The News’ that his Antigen test will be conducted on Tuesday (tomorrow) and if he clears that he will join the team.
Afridi a few days ago had tested positive for covid-19 and is spending isolation at his home while following the PCB covid protocols.
Meanwhile, as a substitute for Afridi, Quetta Gladiators on Saturday requested the technical committee that they should be given Hassan Khan as a replacement for Afridi. And the Gladiators source confirmed that the request has been approved.
The source said that Hassan will also be available for selection for Quetta’s game against Multan Sultans on Monday (today). “We also need players for training and so we requested for Hassan,” the source was quick to add.
The source said if Afridi cleared the Antigen test then he would join the team and Hassan would return to the bubble.
-
What You Need To Know About Ischemic Stroke -
Shocking Reason Behind Type 2 Diabetes Revealed By Scientists -
SpaceX Cleared For NASA Crew-12 Launch After Falcon 9 Review -
Meghan Markle Gives Old Hollywood Vibes In New Photos At Glitzy Event -
Simple 'finger Test' Unveils Lung Cancer Diagnosis -
Groundbreaking Treatment For Sepsis Emerges In New Study -
Roblox Blocked In Egypt Sparks Debate Over Child Safety And Digital Access -
Savannah Guthrie Addresses Ransom Demands Made By Her Mother Nancy's Kidnappers -
OpenAI Reportedly Working On AI-powered Earbuds As First Hardware Product -
Andrew, Sarah Ferguson Refuse King Charles Request: 'Raising Eyebrows Inside Palace' -
Adam Sandler Reveals How Tom Cruise Introduced Him To Paul Thomas Anderson -
Washington Post CEO William Lewis Resigns After Sweeping Layoffs -
North Korea To Hold 9th Workers’ Party Congress In Late February -
All You Need To Know Guide To Rosacea -
Princess Diana's Brother 'handed Over' Althorp House To Marion And Her Family -
Trump Mobile T1 Phone Resurfaces With New Specs, Higher Price